Role of selenium in heart lesions produced by neuroleptics in the rabbit

Journal of Applied Toxicology

Volumn 28, Issue 2, 2008, Pages 212-216

  Vaillant, F ^a   Turrel, F ^a   Bost, M ^b,c   Bricca, G ^a   Descotes, Jacques ^d   Bui Xuan, B ^a   Tabib, A ^e   Manati, W ^a   Timour, Q ^a,b,c,d  

^a UNIVERSITÉ LYON 1   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c Trace Element Institute for UNESCO   (France)

^d Poison Center   (France)

^e Institute of Forensic Medicine   (France)

Author keywords

Heart lesions; Levomepromazine; Neuroleptics; Rabbit; Risperidone; Selenium

Indexed keywords

LEVOMEPROMAZINE; NEUROLEPTIC AGENT; RISPERIDONE; SELENIUM; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD SAMPLING; CONTROLLED STUDY; ENDOCARDIAL FIBROELASTOSIS; FEMALE; HEART INJURY; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTIPSYCHOTIC AGENTS; DOWN-REGULATION; FEMALE; HEART DISEASES; INJECTIONS, INTRAMUSCULAR; KIDNEY; LIVER; METHOTRIMEPRAZINE; MYOCARDIUM; RABBITS; RISPERIDONE; SELENIUM;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 41149165795     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1279     Document Type: Article

References (41)

1. Barry WH. 1994. Mechanisms of immune-mediated myocyte injury. Circulation 89: 2421-2432.
2. Beck MA, Handi J, Levander OA. 2000. The role of oxidative stress in viral infections. Ann. N. Y. Acad. Sci. 917: 906-912.
3. Belhani D, Frassati D, Megard R, Tsibiribi P, Bui-Xuan B, Tabib A, Fanton L, Malicier D, Descotes J, Timour Q. 2006. Cardiac lesions induced by neuroleptic drugs in the rabbit. Exp. Toxicol. Pathol. 57: 207-212.
4. Burniston JG, Ellison GM, Clark WA, Goldspink DF, Tan LB. 2005. Relative toxicity of cardiotonic agents: some induce more cardiac and skeletal myocyte apoptosis and necrosis in vivo than others. Cardiovasc. Toxicol. 5: 355-364.
5. Campillo N, Vinas P, Lopez-Garcia I, Hernandez-Cordoba M. 2000. Selenium determination in biological fluids using Zeeman background correction electrothermal atomic absorption spectrometry. Anal. Biochem. 280: 195-200.
6. Cook DJ, Housmans PR, Rorie DK. 1992. Effect of ketamine HCl on norepinephrine disposition in isolated ferret ventricular myocardium. J. Pharmacol. Exp. Ther. 261: 101-107.
7. Davidson M. 2002. Risk of cardiovascular disease and sudden death in schizophrenia. J. Clin. Psychiatry 917: 906-912.
8. Descotes J, Lievre M, Faucon G, Evreux JC. 1979. Effect of levomepromazine on atrioventricular conduction tissue. Toxicol. Eur. Res. 2: 87-92.
9. Diplock AT. 1994. Antioxidants and disease prevention. Mol. Aspects Med. 15: 293-376.
10. Frassati D, Tabib A, Lachaux B, Giloux N, Dalery J, Vittori F, Charvet D, Barel C, Bui-Xuan B, Megard R, Jenoudet LP, Descotes J, Vial T, Timour Q. 2004. Hidden cardiac lesions and psychotropic drugs as a possible cause of sudden death in psychiatric patients: a report of 14 cases and review of the literature. Can. J. Psychiatry 49: 100-105.
11. Goldspink DF, Burniston JG, Ellison GM, Clark WA, Tan LB. 2004. Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? Exp. Physiol. 89: 407-416.
12. Hauben M. 1999. Sudden death in a patient taking antipsychotic drugs. Postgrad. Med. J. 75: 127.
13. Ishikawa Y, Sekiguchi K, Akasaka Y, Ito K, Akishima Y, Zhang L, Itoh M, Ishihara M, Ishii T. 2003. Fibromuscular dysplasia of coronary arteries resulting in myocardial infarction associated with hypertrophic cardiomyopathy in Noonan's syndrome. Hum. Pathol. 34: 282-284.
14. Kishimoto C, Hiraoka Y. 1994. Clinical and experimental studies in myocarditis. Curr. Opin. Cardiol. 9: 349-356.
15. Klevay LM, Rennen OM, Can WY, et al. 1984. The role of copper, zinc and other chemical element in ischemic heart disease. In Metabolism of Trace Metals in Man, vol 1. CRC Press: Boca Raton; 129-157.
16. Kosar F, Sahin I, Acikgoz N, Aksoy Y, Kucukbay Z, Cehreli S. 2005. Significance of serum trace element status in patients with rheumatic heart disease: a prospective study. Biol. Trace Elem. Res. 107: 1-10.
17. Kumar A. 1997. Sudden unexplained death in a psychiatric patient - a case report: the role of phenothiazines and physical restraint. Med. Sci. Law 37: 170-175.
18. Magyar J, Banyasz T, Bagi Z, Pacher P, Szentandrassy N, Fulop L, Kecskemeti V, Nanasi PP. 2002. Electrophysiological effects of risperidone in mammalian cardiac cells. Naunyn Schmiedebergs Arch. Pharmacol. 366: 350-356.
19. Michiels C, Raes M, Toussaint O, Remade J. 1994. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic. Biol. Med. 17: 235-248.
20. Neve J. 1991. Physiological and nutritional importance of selenium. Experientia 47: 187-193.
21. Neve J. 1996. Selenium as a risk factor for cardiovascular diseases. J. Cardiovasc. Risk 3: 42-47.
22. Newman SC, Bland RC. 1991. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can. J. Psychiatry 36: 239-245.
23. Oster O, Prellwitz W. 1990. Selenium and cardiovascular disease. Biol. Trace Elem. Res. 24: 91-103.
24. Passwal M, Dahl SG, Refsum H. 1976. Anticholinergic and cardiodepressive effects of levomepromazine and two of its metabolites on isolated rat atria. Eur. J. Pharmacol. 40: 249-254.
25. Peretz AM, Neve JD, Famaey JP. 1991. Selenium in rheumatic diseases. Semin Arthritis Rheum. 20: 305-316.
26. Pietinen P, Vartiainen E, Seppanen R, Aro A, Puska P. 1996. Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk. Prev. Med. 25: 243-250.
27. Rakotovao A, Tanguy S, Toufektsian MC, et al. 2005. Selenium status as determinant of connexin-43 dephosphorylation in ex vivo ischemic/reperfused rat myocardium. J. Trace Elem. Med. Biol. 19: 43-47.
28. Razzolini R, Boffa GM, De Conti F, Ramondo A, Isabella G, Angelini A, Valente M, Thiene G, Stritoni P, Chioin R. 1993. Morphofunctional correlations in dilated cardiomyopathies. Cardiologia 38: 87-95.
29. Ren G, Dewald O, Frangogiannis NG. 2003. Inflammatory mechanisms in myocardial infarction. Curr. Drug Targets Inflamm. Allergy 2: 242-256.
30. Rossi MA. 1991. Patterns of myocardial fibrosis in idiopathic cardiomyopathies and chronic Chagasic cardiopathy. Can. J. Cardiol. 7: 287-294.
31. Salonen JT, Alfthan G, Piikkarrainen J, Huttunen JK, Puska P. 1982. Association between cardiovascular death and myocardial infarction and serum selenium in a matched pair longitudinal study. Lancet ii: 175-179.
32. Salonen JT, Salonen R, Seppaenen K, Kantola M, Parviainen M, Alfthan G, Maenpaa PH, Taskinen E, Rauramaa R. 1988. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischemic hearth disease in Eastern Finnish men. Atherosclerosis 70: 155-165.
33. Snaith RP. 1999. Antipsychotic polypharmacy and early death. Br. J. Psychiatry 174: 368-369.
34. Straus SM, Bleumink GS, Dieleman JP, van der Lei J, 't Jong GW, Kingma JH, Sturkenboom MC, Strieker BH. 2004. Antipsychotics and the risk of sudden cardiac death. Arch. Intern. Med. 164: 1839.
35. Sunde RA, O'Dell BL. 1997. Handbook of Nutritionally Essential Mineral Elements. Marcel Dekker: New York; 493-556.
36. Tanguy S, Boucher F, Besse S, Ducros V, Favier A, de Leiris J. 1998. Trace elements and cardioprotection: increasing endogenous glutathione peroxidase activity by oral selenium supplementation in rats limits reperfusion-induced arrhythmias. J. Trace Elem. Med. Biol. 12: 28-38.
37. Todd GL, Baroldi G, Pieper GM, Clayton FC, Eliot RS. 1985. Experimental catecholamine-induced myocardial necrosis. I. Morphology, quantification and regional distribution of acute contraction band lesions. J. Mol. Cell Cardiol. 17: 317-338.
38. Vaddadi KS, Soosai E, Vaddadi G. 2003. Low blood selenium concentrations in schizophrenic patients on clozapine. Br. J. Clin. Pharmacol. 55: 307-309.
39. Van Vleet JF, Ferrans VJ, Weirich WE. 1980. Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants. Am. J. Pathol. 99: 13-42.
40. Virtamo J, Valkiela E, Alfthan G, Punsar S, Huttunen JK, Karvonen MJ. 1985. Serum selenium and the risk of coronary heart disease and stroke. Am. J. Epidemiol. 122: 276-282.
41. Wojcicki J, Rozewicka L, Barcew-Wiszniewska B, Samochowiec L, Juzwiak S, Kadlubowska D, Tustanowski S, Juzyszyn Z. 1991. Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 87: 9-16.